Syncom Formulations (India) Ltd banner
S

Syncom Formulations (India) Ltd
NSE:SYNCOMF

Watchlist Manager
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Watchlist
Price: 12.31 INR -3.75%
Market Cap: ₹11.6B

Syncom Formulations (India) Ltd
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Syncom Formulations (India) Ltd
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
S
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Other Items
-₹82.4m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Items
-₹7.1B
CAGR 3-Years
-28%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Items
-₹12.3B
CAGR 3-Years
-8%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Items
-₹55.9B
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Other Items
-₹42B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Items
-₹131.8m
CAGR 3-Years
49%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Syncom Formulations (India) Ltd
Glance View

Market Cap
11.6B INR
Industry
Pharmaceuticals

Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.

SYNCOMF Intrinsic Value
17.39 INR
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Syncom Formulations (India) Ltd's Other Items?
Other Items
-82.4m INR

Based on the financial report for Mar 31, 2025, Syncom Formulations (India) Ltd's Other Items amounts to -82.4m INR.

What is Syncom Formulations (India) Ltd's Other Items growth rate?
Other Items CAGR 3Y
19%

The average annual Other Items growth rates for Syncom Formulations (India) Ltd have been 19% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett